TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Cash flows from operating activities
Net Income
-176,145
-176,145
-132,617
-76,925
-89,875
Depreciation & amortization
1,391
1,391
294
213
132
Stock based compensation
10,694
10,694
8,662
6,889
17,411
Change in working capital
-14,000
-14,000
16,364
-6,337
665
Accounts receivable
-13,640
-13,640
-6,951
168
-3,976
Inventory
-8,593
-8,593
-1,782
-409
-386
Accounts Payable
-3,563
-3,563
18,646
-3,261
4,232
Other working capital
-189,590
-189,590
-128,134
-76,983
-70,384
Other non-cash items
1,919
1,919
270
-
-
Net cash provided by operating activites
-165,698
-165,698
-106,812
-76,156
-69,142
Cash flows from investing activities
Investments in property, plant and equipment
-23,892
-23,892
-21,322
-827
-1,241
Other investing activites
-20
-20
-175
-
-14
Net cash used for investing activites
-23,913
-23,913
-21,498
-827
-1,255
Cash flows from financing activities
Debt repayment
-81,661
-81,661
-
-
-
Common stock issued
77,031
77,031
89,908
68,573
134,863
Other financing activites
-6,652
-6,652
-3,787
-
-
Net cash used privided by (used for) financing activities
188,827
188,827
162,787
72,584
137,226
Net change in cash
-783
-783
34,477
-4,398
66,828
Cash at beginning of period
161,613
161,613
127,136
131,534
64,706
Cash at end of period
160,830
160,830
161,613
127,136
131,534
Free Cash Flow
Operating Cash Flow
-165,698
-165,698
-106,812
-76,156
-69,142
Capital Expenditure
-23,892
-23,892
-21,322
-827
-1,241
Free Cash Flow
-189,590
-189,590
-128,134
-76,983
-70,384